InnoCan Pharma Corporation (INNPF OTCQB) stock market data APIs
$4.3878
0(0%)
as of May 7, 2026
Try our APIs with
free plan!
InnoCan Pharma Corporation Financial Data Overview
Price chart is built with
Anychart
InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments, Online sales and Other Operations. The company develops a cannabidiol (CBD)-loaded liposome drug delivery platform (CBD-LPT), which is in the preclinical trial phase to treat chronic pain management for human and veterinary health sectors. It also offers a pain-relieving topical composition, as well as compositions for the treatment of hemorrhoid, psoriasis of the scalp, vaginal atrophy, and diabetic symptoms. The company is also involved in development, manufacture, and marketing of cosmetic products. InnoCan Pharma Corporation was founded in 2017 and is headquartered in Calgary, Canada.
Prev. Close
4.3878
Open
4.3878
High
4.3878
Low
4.3878
52 wk Range
0.1145-14.26
Market Cap
19 795 K
Shares Outstanding
4 499 K
Revenue
26 612 K
EPS
0.4435
Beta
-0.251
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get InnoCan Pharma Corporation data using free add-ons & libraries
Get InnoCan Pharma Corporation Fundamental Data
InnoCan Pharma Corporation Fundamental data includes:
- Net Revenue: 26 612 K
- EBITDA: -1 213 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get InnoCan Pharma Corporation Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-03-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
InnoCan Pharma Corporation News
New
Innocan Pharma To List On NYSE American With Concurrent Offering
(RTTNews) - Innocan Pharma (INNPF) announced that it anticipates to list on NYSE American on or around January 7, 2026. Innocan is also conducting a concurrent offering of its securities. Innocan exp...
Innocan Pharma Announces Details of Proposed Share Consolidation
HERZLIYA, Israel and CALGARY, Alberta, Aug. 29, 2025 /CNW/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that further to its ...
Innocan Pharma Announces Brokered LIFE Offering of Units for Up to $3 Million
NOT FOR DISSEMINATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HERZLIYA, Israel and CALGARY, Alberta, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Innocan Pharma Corporation...
Innocan Pharma Reports Successful Results of Efficacy Test for Vaginal Derma Product
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 23, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology com...
Get InnoCan Pharma Corporation fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
